Literature DB >> 10956311

Improving patient outcomes in heart failure: evidence and barriers.

J G Cleland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956311      PMCID： PMC1766537          DOI： 10.1136/heart.84.suppl_1.i8

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  13 in total

1.  ACE inhibitors still the drug of choice for heart failure--and more.

Authors:  E Topol
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

2.  Is the prognosis of heart failure improving?

Authors:  J G Cleland; I Gemmell; A Khand; A Boddy
Journal:  Eur J Heart Fail       Date:  1999-08       Impact factor: 15.534

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?

Authors:  G S Hillis; R J Trent; P Winton; A M MacLeod; K P Jennings
Journal:  QJM       Date:  1996-02

5.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

6.  Cardiac transplantation.

Authors:  N E Shumway
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

7.  Changing patterns of investigation and treatment of cardiac failure in hospital.

Authors:  G S Hillis; A Al-Mohammad; M Wood; K P Jennings
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

8.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

9.  Prevalence, aetiology and management of heart failure in general practice.

Authors:  F S Mair; T S Crowley; P E Bundred
Journal:  Br J Gen Pract       Date:  1996-02       Impact factor: 5.386

10.  Noncompliance with congestive heart failure therapy in the elderly.

Authors:  M Monane; R L Bohn; J H Gurwitz; R J Glynn; J Avorn
Journal:  Arch Intern Med       Date:  1994-02-28
View more
  4 in total

1.  Cardiac stem cells: translation to human studies.

Authors:  Zijun Ge; Sean Lal; Thi Y L Le; Cris Dos Remedios; James J H Chong
Journal:  Biophys Rev       Date:  2014-12-03

Review 2.  Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.

Authors:  Emile Levy; Pierre Levy
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis.

Authors:  Robyn A Clark; Sally C Inglis; Finlay A McAlister; John G F Cleland; Simon Stewart
Journal:  BMJ       Date:  2007-04-10

Review 4.  beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

Authors:  Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
Journal:  Drugs Aging       Date:  2007       Impact factor: 4.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.